Medicated chewing gums have a wide range of applications in health care, including drug delivery and neutraceuticals. These gums are used for the prevention and treatment of motion sickness and dental caries and smoking for cessation. The popularity of chewing gums as drug delivery systems is increasing due to their advantages such as non-invasiveness, easy administration, and faster metabolism through the liver or gut wall. Moreover, the trend of using biodegradable chewing gums is increasing due to a ban on synthetic polymer-based chewing gums in Singapore and other parts of the world.

Read Report Overview -

https://www.transparencymarketresearch.com/medicated-chewing-gums-m...

Factors driving the growth of the global medicated chewing gums market are large population base addicted to smoking and increase in awareness about dental hygiene and bad breath. Additionally, an increase in demand for medicated chewing gums in neutraceuticals and drug delivery are anticipated to fuel the market during the forecast period.

Furthermore, a large number of variants of nicotine gum manufactured by market players, including various flavors such as mint and fruits, is expected to fuel the medicated chewing gums market. Moreover, an increase in the use of chewing gums as drug delivery systems for the prevention and treatment of nausea and motion sickness is expected to offer growth opportunities to the medicated chewing gums market.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B...

The global medicated chewing gums market can be segmented based on product, application, and region. In terms of product, the medicated chewing gums market can be divided into pellets, hollow balls, liquid-filled gum, others. The pellets segment is projected to account for a major market share during the forecast period due to an increase in the availability of medicated chewing gums in the pellet form.

Based on application, the global medicated chewing gums market can be classified into smoking cessation, dental hygiene, motion sickness, dental caries, and others. The smoking cessation segment is anticipated to be driven by a rise in addiction to smoking and increase in awareness about smoking cessation methods among men and women.

Get COVID-19 Analysis on Medicated Chewing Gums Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=c...

In terms of region, the global medicated chewing gums market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The medicated chewing gums market in North America is anticipated to exhibit significant growth due to factors such as increase in the number of adults addicted to smoking and significant demand for dental hygiene products such as chewing gums and mouth washes. The medicated chewing gums market in Europe is projected to expand at a rapid pace during the forecast period, due to a significant presence of market players manufacturing nicotine-based medicated chewing gums and expansion of the neutraceutical industry in countries such as Germany, France, and the U.K.

The medicated chewing gums market in Asia Pacific is expected to be driven by a rise in the number of consumers using medicated chewing gum and active pharmaceutical ingredient (API) manufacturers and increasing importance of dental healthcare due to a rise in the prevalence of dental caries. Furthermore, a rise in the number of government initiatives for smoking cessation is anticipated to fuel the market in emerging economies such as China and India.

Enquiry Before Buying -

https://www.transparencymarketresearch.com/sample/sample.php?flag=E...

In India, research and innovation is one of the key factors responsible for the growth of health care technologies. For instance, the School of Pharmaceutical and Sciences, Rajiv Gandhi Proudyog Vishwavidyala (RGPV), developed a biodegradable medical chewing gum for travelers with motion sickness. Furthermore, outsourcing of manufacturing processes by Enorama Pharma to Aizant, a contract manufacturing organization (CRO) company in India, is expected to offer growth opportunities to the medicated chewing gums market in India.

Key players operating in the global Medicated Chewing Gums market are Fertin Pharma, Skyepharma Production SAS, Alkalon A/S, GlaxoSmithKline, ENORAMA PHARMA AB, Mastix LLC, Omega Pharma Ltd, a subsidiary of Perrigo Company Plc., Agro Gums, Perfetti Van Melle, and WM. Wrigley Jr. Company.

More Trending Reports by Transparency Market Research –

Centrifuge Market:

https://www.globenewswire.com/news-release/2022/03/01/2393938/0/en/...

Companion Diagnostics Market:

https://www.prnewswire.co.uk/news-releases/companion-diagnostics-ma...

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/